Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details)

v3.23.1
Significant Accounting Policies (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Jan. 01, 2023
Feb. 28, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 17, 2015
Significant Accounting Policies          
Percentage of shares issued for offering and annual equity fee         2.50%
Fortress Biotech, Inc          
Significant Accounting Policies          
Percentage of shares issued for offering and annual equity fee 2.50%     2.50%  
Number of shares issued 368,907 35,714      
Research and development          
Significant Accounting Policies          
Value of common stock shares issued     $ 1.9